Back

Averaged decrease in SpO2 during 6-minute walk test as a novel prognostic marker for elderly heart failure patients

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - epidemiology, prognosis, outcome 7 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Isamu Sunayama

Hyogo College of Medicine, Nishinomiya (Japan)

6 More presentations in this session

Presentation thumbnail
Real world management of heart failure across the spectrum of left ventricle ejection fraction. A report from the Spanish Society of Cardiology-Excellence Heart Failure project.
Doctor A. Recio Mayoral (Seville, ES)
Abstract Slides Video
Presentation thumbnail
Gender differences in health-related quality of life in patients with heart failure
Doctor A. Rao (New York City, US)
Abstract Slides Video
Presentation thumbnail
Vascular endothelial growth factor-A SNPs as predictors of hospitalisation for acute heart failure in patients with established coronary heart disease.
Mr J. Meza Alvarado (Wellington, NZ)
Abstract Slides Video
Presentation thumbnail
Predicting survival in patients with severe heart failure: risk scores validation in the HELP-HF cohort
Doctor M. Chiarito (Rozzano, IT)
Abstract Slides Video
Presentation thumbnail
Predicting heart failure outcomes with a new Malnutrition and Inflammation Severity Index - MISI Score
Doctor F. Rodrigues Santos (Viseu, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - epidemiology, prognosis, outcome 7

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Six-minute walk distance as a prognostic predictor in acute heart failure
thumbnail
Congress Presentation
Implications of six-minute walk test in patients with cardiovascular diseases for estimating clinical outcomes
thumbnail
Congress Presentation
Predicting mortality in chronic heart failure: combined evaluation of VE/VCO2 and pVO2 independent of LVEF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources